209 related articles for article (PubMed ID: 16848870)
1. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N
Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870
[TBL] [Abstract][Full Text] [Related]
2. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
3. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
5. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
[TBL] [Abstract][Full Text] [Related]
6. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
7. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S
J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
[TBL] [Abstract][Full Text] [Related]
8. Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients.
Plank C; Benz K; Amann K; Nüsken KD; Dittrich K; Rascher W; Sauerstein K; Stuppy A; Klare B; Dötsch J
Nephrol Dial Transplant; 2006 Oct; 21(10):2930-7. PubMed ID: 16837512
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A
Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386
[TBL] [Abstract][Full Text] [Related]
10. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
[TBL] [Abstract][Full Text] [Related]
11. Patterns of chronic injury in pediatric renal allografts.
Dart AB; Schall A; Gibson IW; Blydt-Hansen TD; Birk PE
Transplantation; 2010 Feb; 89(3):334-40. PubMed ID: 20145525
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival.
Kaminska D; Bernat B; Mazanowska O; Krasnowski R; Polak W; Patrzalek D; Kochman A; Klinger M
Transplant Proc; 2006; 38(1):59-61. PubMed ID: 16504664
[TBL] [Abstract][Full Text] [Related]
13. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.
Carmellini M; Collini A; Ruggieri G; Garosi G; Bernini M
Transplant Proc; 2008; 40(6):1858-61. PubMed ID: 18675070
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
15. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
[TBL] [Abstract][Full Text] [Related]
17. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.
Conti DJ; Petrov R; Elbalhoul O; Gallichio M
Transpl Immunol; 2008 Nov; 20(1-2):12-3. PubMed ID: 18793727
[TBL] [Abstract][Full Text] [Related]
20. Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.
Roos-van Groningen MC; Scholten EM; Lelieveld PM; Rowshani AT; Baelde HJ; Bajema IM; Florquin S; Bemelman FJ; de Heer E; de Fijter JW; Bruijn JA; Eikmans M
J Am Soc Nephrol; 2006 Mar; 17(3):881-8. PubMed ID: 16467444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]